Applied Finance Capital Management, LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1966007 SAN JUAN, PR

Position in REGN

as of Jun 30, 2026 · filed Jul 28, 2026 Compact

Position Value

$8,550,604

-$4,456,790 QoQ

Shares Held

13,713

-18.5% QoQ

Ownership

0.013%

of shares outstanding

% of Portfolio

0.65%

of 13F equity value

Holder Rank

#318

of 1,322 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 99% Shared 0% None 1%

Healthcare · as of Jun 30, 2026

Applied Finance Capital Management, LLC holds $21,094,509 across 4 Biotechnology names. REGN ranks #2 (40.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INCY	Incyte Corp	106,768	$12,103,220
2	REGN	Regeneron Pharmaceuticals, Inc. This page	13,713	$8,550,604
3	JAZZ	Jazz Pharmaceuticals plc	970	$233,740
4	HALO	Halozyme Therapeutics, Inc.	2,644	$206,945

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$8,550,604	13,713	-18.5%	Shares	Sole	2026-07-28
2026-03-31	$13,007,394	16,835	-11.8%	Shares	Sole	2026-05-04
2025-12-31	$14,728,051	19,081	-14.1%	Shares	Sole	2026-02-05
2025-09-30	$12,493,077	22,219	-3.3%	Shares	Sole	2025-11-06
2025-06-30	$12,066,075	22,983	+16.1%	Shares	Sole	2025-07-29
2025-03-31	$12,553,314	19,793	-30.1%	Shares	Sole	2025-05-07
2024-12-31	$20,171,048	28,317	+0.2%	Shares	Sole	2025-02-13
2024-09-30	$29,711,196	28,263	-6.3%	Shares	Sole	2024-11-08
2024-06-30	$31,691,707	30,153	+36.1%	Shares	Sole	2024-07-31
2024-03-31	$21,322,040	22,153	-0.6%	Shares	Sole	2024-05-07
2023-12-31	$19,572,692	22,285	+8.8%	Shares	Sole	2024-02-08
2023-09-30	$16,855,866	20,482	+9.3%	Shares	Sole	2023-11-08
2023-06-30	$13,468,313	18,744	-11.1%	Shares	Sole	2023-08-14
2023-03-31	$17,318,338	21,077	+1.1%	Shares	Sole	2023-05-12
2022-12-31	$15,046,673	20,855	—	Shares	Sole	2023-02-15
No filing history on record for this holder in this stock.